TESTOSTERONFORMULIERUNGEN

European patent · EP3072505 · Deleted

Register entry

Publication number
EP3072505
Application number
EP16169138
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 18, 2012
Published
Sep 28, 2016
Granted
Jun 12, 2019
Deleted
Aug 24, 2022
Reason
Annual fee unpaid
IPC classes
A61K 9/06 (2006.01)
A61K 47/10 (2017.01)
A61P 5/26 (2006.01)
A61K 31/568 (2006.01)
Priority
EP 11152210 26.01.2011
US 201161436207 P 26.01.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 24, 2022

    Deleted, fee unpaid

    Published in Swissreg on 24.08.2022

  2. Jun 13, 2019

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 13.06.2019

  3. Jun 12, 2019

    Granted

    Published in Swissreg on 12.06.2019

Parties

Holder

Ferring B.V.

Polaris Avenue 144, 2132 JX Hoofddorp, NL

Agent

Valipat S.A. c/o BOVARD SA Neuchâtel

Rue des Noyers 11, 2000 Neuchâtel

Inventor

Carrara, Dario N.

4104 Oberwil

Grenier, Arnaud

68440 Steinbrunn le Haut, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.